OBESE-EIT: Evaluation of Regional Lung Mechanics in Obese Patients Undergoing Laparoscopic Surgery

Sponsor
Università degli Studi di Ferrara (Other)
Overall Status
Recruiting
CT.gov ID
NCT05554536
Collaborator
(none)
30
1
1
16.2
1.9

Study Details

Study Description

Brief Summary

This study will evaluate what is the impact of laparoscopy and Trendelenburg position on lung regional ventilation distribution in obese patients, focusing on the differences between the different phases of surgery.

Condition or Disease Intervention/Treatment Phase
  • Procedure: PEEP titration trial
N/A

Detailed Description

Electrical impedance tomography (EIT) is a non invasive monitoring technique that allows to evaluate the regional distribution of ventilation. EIT has been used in different contexts, such as acute respiratory failure or intraoperative ventilation settings. Obesity, by increasing intrabdominal pressure, may reduce functional residual capacity after anesthesia and therefore require a more aggressive intraoperative ventilatory setting. In addition, laparoscopy, by increasing the volume of the abdomen, further pushes the diaphragm and increase the probability of lung collapse.

The aim of the current study is to describe the effect of 1) anesthesia and of 2) laparoscopy and trendelenburg position on regional ventilation distribution. Moreover, the investigators will evaluate if the best ventilatory parameters set after anesthesia induction are confirmed also when the condition changes (i.e. during pneumoperitoneum and trendellenburg).

Finally, the investigators will explore if the different parameters which can be provided by EIT agree in suggesting the best level of positive-end expiratory pressure in both moments of surgery.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Evaluation of Regional Lung Mechanics in Obese Patients Undergoing Laparoscopic Surgery Using Electrical Impedance Tomography
Actual Study Start Date :
Feb 22, 2022
Anticipated Primary Completion Date :
Apr 30, 2023
Anticipated Study Completion Date :
Jun 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Other: Single arm intervention

All patients will undergo a PEEP titration trial in each surgery step (before pneumoperitoneum, during pneumoperitoneum, after pneumoperitoneum). The PEEP titration trial will be done in steps of 2 cmH2O, starting from clinical PEEP 16 cmH2O and ending to PEEP 6 cmH2O. Each PEEP level will be kept for 2 minutes. The PEEP titration trial will be stopped in case of haemodynamic instability or severe desaturation (Spo2 < 92%). Each PEEP titration trial will be recorded using Electrical impedance tomography (EIT).

Procedure: PEEP titration trial
PEEP trial, starting from clinical PEEP 16 cmH2O and ending at PEEP 6 cmH2O. The PEEP trial will be stopped for haemodynamic instability (defined as arterial pressure < 80 mmHg and /or heart rate > 150 bpm) or desaturation (defined as SpO2 < 92%).

Outcome Measures

Primary Outcome Measures

  1. Best Positive end-expiratory pressure - Laparoscopy variability [Difference between the best PEEP after anesthesia induction and during pneumoperitoneum]

    The primary outcome will be the best PEEP found using the PEEP titration trial.

Secondary Outcome Measures

  1. Best Positive end-expiratory pressure - EIT variability [After anesthesia induction, during pneumoperitoneum, end of surgery]

    Secondary outcome will be to compare the different values of best PEEP provided by several parameters of EIT to evaluate if the overlap.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • age 18-90 years

  • Body mass index > 30 kg/m2

  • Major surgery

  • Predicted duration of surgery > 2 hours

  • Predicted presence of invasive arterial pressure monitoring

Exclusion Criteria:
  • emergency surgery

  • Refuse to participate from patient

  • presence of Implantable cardiac device or pacemaker

  • thoracic wounds

  • thoracic surgery

Contacts and Locations

Locations

Site City State Country Postal Code
1 Azienda Ospedaliero Universitaria Sant'Anna Ferrara Italy 44121

Sponsors and Collaborators

  • Università degli Studi di Ferrara

Investigators

  • Study Director: Savino Spadaro, MD, PhD, Università degli Studi di Ferrara

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Savino Spadaro, Clinical Professor, Università degli Studi di Ferrara
ClinicalTrials.gov Identifier:
NCT05554536
Other Study ID Numbers:
  • OBESE-EIT
First Posted:
Sep 26, 2022
Last Update Posted:
Sep 26, 2022
Last Verified:
Sep 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Savino Spadaro, Clinical Professor, Università degli Studi di Ferrara
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 26, 2022